$66.580
-0.366 (-0.55%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BMY Prediction & Forecast by Similar Chart Analysis
Alphio's BMY stock price prediction model matches the current Bristol-Myers Squibb Company tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $66.74 (+0.24%). The 1-week path is $66.24 (-0.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Bristol-Myers Squibb Company Stock?
Bristol-Myers Squibb Co is a good buy right now due to its current price of $66.58, a forward P/E ratio of 9.70, and a solid 3.8% dividend yield. The company has shown a 40.43% increase in stock price over the past year, driven by strong clinical advancements in its products. However, the main risk is the upcoming patent expiration for its key drug Eliquis in 2028, which could significantly impact revenue.
BMY stock price ended at $66.58 on Friday, after losing -0.55%
Bristol-Myers Squibb Company (BMY) last closed at $66.58, losing -0.55%. These facts feed the 1-day and 1-week BMY price prediction above.
Analyst Consensus
Bristol-Myers Squibb Company (BMY): 9 buy, 11 hold, 2 sell. Outlook: Hold.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Bristol-Myers Squibb Company (BMY) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches BMY, ranked by similarity.
Seasonality analysis for BMY
Historically the probability of a positive August return for BMY is 31.75%. March offers the highest probability of a positive month at 79.37%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BMY
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $41.12 | $51.40 | $54.32 | -22.81% |
| Sep 2026 | $46.67 | $47.66 | $58.01 | -28.42% |
| Oct 2026 | $36.20 | $46.76 | $54.35 | -29.77% |
| Nov 2026 | $34.69 | $40.66 | $49.98 | -38.93% |
| Dec 2026 | $35.77 | $40.66 | $44.66 | -38.93% |
In 2026, Bristol-Myers Squibb Company (BMY) is projected to range from $34.69 to $58.01.
Bristol-Myers Squibb Company 2026 monthly forecast
In Aug 2026, Bristol-Myers Squibb Company is projected to average $51.40, with a low of $41.12 and high of $54.32.
In Sep 2026, Bristol-Myers Squibb Company is projected to average $47.66, with a low of $46.67 and high of $58.01.
In Oct 2026, Bristol-Myers Squibb Company is projected to average $46.76, with a low of $36.20 and high of $54.35.
In Nov 2026, Bristol-Myers Squibb Company is projected to average $40.66, with a low of $34.69 and high of $49.98.
In Dec 2026, Bristol-Myers Squibb Company is projected to average $40.66, with a low of $35.77 and high of $44.66.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.